1. T HE A LLIANCE FOR B IOMEDICAL R ESEARCH IN E UROPE ‘H IGH - LEVEL MEETING TO BRAINSTORM WITH KEY DRIVERS IN EU HEALTH RESEARCH POLICY ’ E UROPEAN P ARLIAMENT · 24 J ANUARY 2012 O RGANIZED BY M ARIA DA G RAÇA C ARVALHO MEP I Prof Ulf Smith, President, Alliance for Biomedical Research in Europe

2. Alliance for Biomedical Research in Europe O UR M EMBERSHIP

3. Alliance for Biomedical Research in Europe 1.Boost biomedial research with appropriate resourcing at the EU level 2.Implement structured consultation with the biomedical researchers to ensure proper targeting and priority-setting for funding 3.Create an interconnected and coherent EU biomedical research programme, including the creation of a ”European Council of Health” 4.Enhance international cooperation and global initiatives

4. Societal health challenges in Europe  An ageing population  Growing prevalence of chronic diseases  A declining labour force  Rising health care costs Alliance for Biomedical Research in Europe

5. Expected rise in direct health care costs Source: pwc (2011) Medical Technology Innovation Scoreboard. The race for global leadership. Health expenditure per capita, USD

6. * A report by the World Economic Forum and the Harvard School of Public Health - September 2011 The NCD (non-communicable disease) cost tally * Lost output from five conditions (cancer, cardiovascular disease, chronic respiratory diseases, diabetes and mental health) over period 2011-2030 is estimated at nearly US$ 47 trillion. Alliance for Biomedical Research in Europe

7. H EALTH Alliance for Biomedical Research in Europe H ORIZON 2020: P ROPOSED FUNDING FOR S OCIETAL C HALLENGES (€ BILLION )

8. Does it pay to invest in biomedical research? “… the total health and GDP gains to public/charitable CVD research in the UK 1975–1992 give a total Initial Rates of Return (IRR) of around 39%. In other words, a £1.00 investment in public CVD research produced a stream of benefits that is equivalent in value to earning £0.39 per year in perpetuity”. “Medical Research: What’s it worth? ” - UK Medical Research Council Report 2008 Alliance for Biomedical Research in Europe

9. Health is Wealth The ageing European population with chronic diseases will dramatically escalate healthcare costs. This challenge can only be met by increased knowledge through biomedical research and an integrated and strategic European platform engaging all key stakeholders in healthcare. Healthcare research is a driving factor for investment and employment. (For instance, EFPIA employs 640 000 people and accounts for over 25% of European high-tech exports.)

10. Alliance for Biomedical Research in Europe “I F YOU THINK RESEARCH IS EXPENSIVE ; TRY DISEASE ” Mary Lasker, 1901–94

11. WWW. BIOMEDEUROPE. ORG ‘H IGH - LEVEL MEETING TO BRAINSTORM WITH KEY DRIVERS IN EU HEALTH RESEARCH POLICY ’ E UROPEAN P ARLIAMENT · 24 J ANUARY 2012 O RGANIZED BY M ARIA DA G RAÇA C ARVALHO MEP I Prof Ulf Smith, President, Alliance for Biomedical Research in Europe